OM

Ovais Mudabbir Bardi

Director Director DIN 06793537
DIN 06793537 First appointment Mar 2014 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Mar 2014
Shareholding value Locked Premium profile

About Ovais Mudabbir Bardi

Ovais Mudabbir Bardi has 12 years in corporate governance. Holds Director role. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations.

DIN 06793537
Primary Designation Director
First Appointment 05 Mar 2014
Oldest Company Age 12 yrs

Current companies

No current companies available.

Previous companies

Company Designation Appointment Founded Status
Cureman Pharmaceuticals Private Limited U74999MH2014PTC253850
Director 05 Mar 2014 2014 Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Cureman Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Ovais Mudabbir Bardi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ovais Mudabbir Bardi

Ovais Mudabbir Bardi has 12 years in corporate governance. Holds Director role. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations.

Ovais Mudabbir Bardi is associated with 0 companies as Director.

Ovais Mudabbir Bardi has expertise in General Business.

Ovais Mudabbir Bardi has 12 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available